Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 157 entries
Sorted by: Best Match Show Resources per page
Pair-distribution function of active Brownian spheres in two spatial dimensions: Simulation results and analytic representation.

The Journal of chemical physics

Jeggle J, Stenhammar J, Wittkowski R.
PMID: 33687241
J Chem Phys. 2020 May 21;152(19):194903. doi: 10.1063/1.5140725.

We investigate the full pair-distribution function of a homogeneous suspension of spherical active Brownian particles interacting by a Weeks-Chandler-Andersen potential in two spatial dimensions. The full pair-distribution function depends on three coordinates describing the relative positions and orientations of...

Cite
Jeggle J, Stenhammar J, Wittkowski R. Pair-distribution function of active Brownian spheres in two spatial dimensions: Simulation results and analytic representation. J Chem Phys. 2020;152(19):194903doi: 10.1063/1.5140725.
Jeggle, J., Stenhammar, J., & Wittkowski, R. (2020). Pair-distribution function of active Brownian spheres in two spatial dimensions: Simulation results and analytic representation. The Journal of chemical physics, 152(19), 194903. https://doi.org/10.1063/1.5140725
Jeggle, Julian, et al. "Pair-distribution function of active Brownian spheres in two spatial dimensions: Simulation results and analytic representation." The Journal of chemical physics vol. 152,19 (2020): 194903. doi: https://doi.org/10.1063/1.5140725
Jeggle J, Stenhammar J, Wittkowski R. Pair-distribution function of active Brownian spheres in two spatial dimensions: Simulation results and analytic representation. J Chem Phys. 2020 May 21;152(19):194903. doi: 10.1063/1.5140725. PMID: 33687241.
Copy Download .nbib Format: NLM
Persistent luminescence nanoparticles functionalized by polymers bearing phosphonic acid anchors: synthesis, characterization, and .

Nanoscale

Lécuyer T, Bia N, Burckel P, Loubat C, Graillot A, Seguin J, Corvis Y, Liu J, Valéro L, Scherman D, Mignet N, Richard C.
PMID: 35018394
Nanoscale. 2022 Jan 12; doi: 10.1039/d1nr07114a. Epub 2022 Jan 12.

Optical

Cite
Lécuyer T, Bia N, Burckel P, et al. Persistent luminescence nanoparticles functionalized by polymers bearing phosphonic acid anchors: synthesis, characterization, and . Nanoscale. 2022;doi: 10.1039/d1nr07114a.
Lécuyer, T., Bia, N., Burckel, P., Loubat, C., Graillot, A., Seguin, J., Corvis, Y., Liu, J., Valéro, L., Scherman, D., Mignet, N., & Richard, C. (2022). Persistent luminescence nanoparticles functionalized by polymers bearing phosphonic acid anchors: synthesis, characterization, and . Nanoscale, . https://doi.org/10.1039/d1nr07114a
Lécuyer, Thomas, et al. "Persistent luminescence nanoparticles functionalized by polymers bearing phosphonic acid anchors: synthesis, characterization, and ." Nanoscale vol. (2022). doi: https://doi.org/10.1039/d1nr07114a
Lécuyer T, Bia N, Burckel P, Loubat C, Graillot A, Seguin J, Corvis Y, Liu J, Valéro L, Scherman D, Mignet N, Richard C. Persistent luminescence nanoparticles functionalized by polymers bearing phosphonic acid anchors: synthesis, characterization, and . Nanoscale. 2022 Jan 12; doi: 10.1039/d1nr07114a. Epub 2022 Jan 12. PMID: 35018394.
Copy Download .nbib Format: NLM
Author Q&A: Claudia Heggie.

British dental journal

Heggie C.
PMID: 34385646
Br Dent J. 2021 Aug;231(3):178. doi: 10.1038/s41415-021-3355-7.

No abstract available.

Cite
Heggie C. Author Q&A: Claudia Heggie. Br Dent J. 2021;231(3):178doi: 10.1038/s41415-021-3355-7.
Heggie, C. (2021). Author Q&A: Claudia Heggie. British dental journal, 231(3), 178. https://doi.org/10.1038/s41415-021-3355-7
Heggie, Claudia. "Author Q&A: Claudia Heggie." British dental journal vol. 231,3 (2021): 178. doi: https://doi.org/10.1038/s41415-021-3355-7
Heggie C. Author Q&A: Claudia Heggie. Br Dent J. 2021 Aug;231(3):178. doi: 10.1038/s41415-021-3355-7. PMID: 34385646.
Copy Download .nbib Format: NLM
Long-term outcomes of congenital diaphragmatic hernia: A single institution experience.

Journal of pediatric surgery

Gerall CD, Stewart LA, Price J, Kabagambe S, Sferra SR, Schmaedick MJ, Hernan R, Khlevner J, Krishnan US, De A, Aspelund G, Duron VP.
PMID: 34274078
J Pediatr Surg. 2021 Jun 25; doi: 10.1016/j.jpedsurg.2021.06.007. Epub 2021 Jun 25.

BACKGROUND/PURPOSE: As survival rates for patients with congenital diaphragmatic hernia (CDH) increase, long-term sequelae become increasingly prevalent. We present the outcomes of patients who underwent CDH repair at our institution and discuss standardization of follow-up care in our long-term...

Cite
Gerall CD, Stewart LA, Price J, et al. Long-term outcomes of congenital diaphragmatic hernia: A single institution experience. J Pediatr Surg. 2021;doi: 10.1016/j.jpedsurg.2021.06.007.
Gerall, C. D., Stewart, L. A., Price, J., Kabagambe, S., Sferra, S. R., Schmaedick, M. J., Hernan, R., Khlevner, J., Krishnan, U. S., De, A., Aspelund, G., & Duron, V. P. (2021). Long-term outcomes of congenital diaphragmatic hernia: A single institution experience. Journal of pediatric surgery, . https://doi.org/10.1016/j.jpedsurg.2021.06.007
Gerall, Claire D, et al. "Long-term outcomes of congenital diaphragmatic hernia: A single institution experience." Journal of pediatric surgery vol. (2021). doi: https://doi.org/10.1016/j.jpedsurg.2021.06.007
Gerall CD, Stewart LA, Price J, Kabagambe S, Sferra SR, Schmaedick MJ, Hernan R, Khlevner J, Krishnan US, De A, Aspelund G, Duron VP. Long-term outcomes of congenital diaphragmatic hernia: A single institution experience. J Pediatr Surg. 2021 Jun 25; doi: 10.1016/j.jpedsurg.2021.06.007. Epub 2021 Jun 25. PMID: 34274078.
Copy Download .nbib Format: NLM
Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma.

Journal of vascular surgery

Mesar T, Alie-Cusson FS, Lin MJ, Dexter DJ, Rathore A, Stokes GK, Panneton JM.
PMID: 34506888
J Vasc Surg. 2021 Sep 08; doi: 10.1016/j.jvs.2021.08.059. Epub 2021 Sep 08.

OBJECTIVE: Thoracic endovascular aortic repair (TEVAR) is increasingly utilized in the management of acute type B aortic intramural hematoma (TBIMH). Optimal timing for intervention has not been described. The aim of this study was to evaluate TEVAR timing on...

Cite
Mesar T, Alie-Cusson FS, Lin MJ, et al. Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma. J Vasc Surg. 2021;doi: 10.1016/j.jvs.2021.08.059.
Mesar, T., Alie-Cusson, F. S., Lin, M. J., Dexter, D. J., Rathore, A., Stokes, G. K., & Panneton, J. M. (2021). Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma. Journal of vascular surgery, . https://doi.org/10.1016/j.jvs.2021.08.059
Mesar, Tomaz, et al. "Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma." Journal of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jvs.2021.08.059
Mesar T, Alie-Cusson FS, Lin MJ, Dexter DJ, Rathore A, Stokes GK, Panneton JM. Impact of thoracic endovascular aortic repair timing on aortic remodeling in acute type B aortic intramural hematoma. J Vasc Surg. 2021 Sep 08; doi: 10.1016/j.jvs.2021.08.059. Epub 2021 Sep 08. PMID: 34506888.
Copy Download .nbib Format: NLM
IMPACT OF THORACIC ENDOVASCULAR AORTIC REPAIR TIMING ON AORTIC REMODELING IN ACUTE TYPE B AORTIC INTRAMURAL HEMATOMA.

Journal of vascular surgery

Mesar T, Alie-Cusson FS, Lin MJ, Dexter DJ, Rathore A, Stokes GK, Panneton JM.
PMID: 34506888
J Vasc Surg. 2021 Sep 07; doi: 10.1016/j.jvs.2021.08.059. Epub 2021 Sep 07.

INTRODUCTION: Thoracic endovascular aortic repair (TEVAR) is increasingly utilized in the management of acute type B aortic intramural hematoma (TBIMH). Optimal timing for intervention has not been described. The aim of this study was to evaluate TEVAR timing on...

Cite
Mesar T, Alie-Cusson FS, Lin MJ, et al. IMPACT OF THORACIC ENDOVASCULAR AORTIC REPAIR TIMING ON AORTIC REMODELING IN ACUTE TYPE B AORTIC INTRAMURAL HEMATOMA. J Vasc Surg. 2021;doi: 10.1016/j.jvs.2021.08.059.
Mesar, T., Alie-Cusson, F. S., Lin, M. J., Dexter, D. J., Rathore, A., Stokes, G. K., & Panneton, J. M. (2021). IMPACT OF THORACIC ENDOVASCULAR AORTIC REPAIR TIMING ON AORTIC REMODELING IN ACUTE TYPE B AORTIC INTRAMURAL HEMATOMA. Journal of vascular surgery, . https://doi.org/10.1016/j.jvs.2021.08.059
Mesar, Tomaz, et al. "IMPACT OF THORACIC ENDOVASCULAR AORTIC REPAIR TIMING ON AORTIC REMODELING IN ACUTE TYPE B AORTIC INTRAMURAL HEMATOMA." Journal of vascular surgery vol. (2021). doi: https://doi.org/10.1016/j.jvs.2021.08.059
Mesar T, Alie-Cusson FS, Lin MJ, Dexter DJ, Rathore A, Stokes GK, Panneton JM. IMPACT OF THORACIC ENDOVASCULAR AORTIC REPAIR TIMING ON AORTIC REMODELING IN ACUTE TYPE B AORTIC INTRAMURAL HEMATOMA. J Vasc Surg. 2021 Sep 07; doi: 10.1016/j.jvs.2021.08.059. Epub 2021 Sep 07. PMID: 34506888.
Copy Download .nbib Format: NLM
Data related to the mesoscopic structure of iso-graphite for nuclear applications.

Data in brief

März B, Jolley K, Marrow TJ, Zhou Z, Heggie M, Smith R, Wu H.
PMID: 29900365
Data Brief. 2018 May 09;19:651-659. doi: 10.1016/j.dib.2018.05.003. eCollection 2018 Aug.

The data in this article are related to the research article "Mesoscopic structure features in synthetic graphite" (März et al., 2018) [1]. Details of the manufacture of isostatically moulded graphite (iso-graphite), thin foil preparation by focused ion beams (FIB)...

Cite
März B, Jolley K, Marrow TJ, et al. Data related to the mesoscopic structure of iso-graphite for nuclear applications. Data Brief. 2018;19:651-659doi: 10.1016/j.dib.2018.05.003.
März, B., Jolley, K., Marrow, T. J., Zhou, Z., Heggie, M., Smith, R., & Wu, H. (2018). Data related to the mesoscopic structure of iso-graphite for nuclear applications. Data in brief, 19651-659. https://doi.org/10.1016/j.dib.2018.05.003
März, Benjamin, et al. "Data related to the mesoscopic structure of iso-graphite for nuclear applications." Data in brief vol. 19 (2018): 651-659. doi: https://doi.org/10.1016/j.dib.2018.05.003
März B, Jolley K, Marrow TJ, Zhou Z, Heggie M, Smith R, Wu H. Data related to the mesoscopic structure of iso-graphite for nuclear applications. Data Brief. 2018 May 09;19:651-659. doi: 10.1016/j.dib.2018.05.003. eCollection 2018 Aug. PMID: 29900365; PMCID: PMC5997625.
Copy Download .nbib Format: NLM
Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation.

American journal of perinatology

Goldstein M, Krilov LR, Fergie J, Brannman L, Wade SW, Kong AM, Ambrose CS.
PMID: 32299107
Am J Perinatol. 2021 Aug;38:e201-e206. doi: 10.1055/s-0040-1709127. Epub 2020 Apr 16.

OBJECTIVE: The aim of this study is to compare outpatient respiratory syncytial virus (RSV) immunoprophylaxis (IP) use and relative RSV hospitalization (RSVH) rates for infants

Cite
Goldstein M, Krilov LR, Fergie J, et al. Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation. Am J Perinatol. 2020;38:e201-e206doi: 10.1055/s-0040-1709127.
Goldstein, M., Krilov, L. R., Fergie, J., Brannman, L., Wade, S. W., Kong, A. M., & Ambrose, C. S. (2021). Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation. American journal of perinatology, 38e201-e206. https://doi.org/10.1055/s-0040-1709127
Goldstein, Mitchell, et al. "Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation." American journal of perinatology vol. 38 (2021): e201-e206. doi: https://doi.org/10.1055/s-0040-1709127
Goldstein M, Krilov LR, Fergie J, Brannman L, Wade SW, Kong AM, Ambrose CS. Unintended Consequences Following the 2014 American Academy of Pediatrics Policy Change for Palivizumab Prophylaxis among Infants Born at Less than 29 Weeks' Gestation. Am J Perinatol. 2021 Aug;38:e201-e206. doi: 10.1055/s-0040-1709127. Epub 2020 Apr 16. PMID: 32299107; PMCID: PMC8397527.
Copy Download .nbib Format: NLM
High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.

Translational lung cancer research

Li Q, Ma W, Chen S, Tian EC, Wei S, Fan RR, Wang T, Zhou C, Li T.
PMID: 32953510
Transl Lung Cancer Res. 2020 Aug;9(4):1361-1378. doi: 10.21037/tlcr-19-633.

BACKGROUND: We previously showed that α3β1 integrin is a novel cancer biomarker and drug target in non-small cell lung cancer (NSCLC). This study characterized the integrin α3 (ITGA3) expression on patient specimens.METHODS: Tissue microarrays (TMAs) were prepared from archival...

Cite
Li Q, Ma W, Chen S, et al. High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer. Transl Lung Cancer Res. 2020;9(4):1361-1378doi: 10.21037/tlcr-19-633.
Li, Q., Ma, W., Chen, S., Tian, E. C., Wei, S., Fan, R. R., Wang, T., Zhou, C., & Li, T. (2020). High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer. Translational lung cancer research, 9(4), 1361-1378. https://doi.org/10.21037/tlcr-19-633
Li, Qianping, et al. "High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer." Translational lung cancer research vol. 9,4 (2020): 1361-1378. doi: https://doi.org/10.21037/tlcr-19-633
Li Q, Ma W, Chen S, Tian EC, Wei S, Fan RR, Wang T, Zhou C, Li T. High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer. Transl Lung Cancer Res. 2020 Aug;9(4):1361-1378. doi: 10.21037/tlcr-19-633. PMID: 32953510; PMCID: PMC7481578.
Copy Download .nbib Format: NLM
Next-generation sequencing-based clinical metagenomics identifies .

British journal of biomedical science

Galliguez T, Tsou PY, Cabrera A, Fergie J.
PMID: 32993476
Br J Biomed Sci. 2021 Apr;78(2):101-105. doi: 10.1080/09674845.2020.1827846. Epub 2021 Jan 13.

We report a 12-year-old diabetic boy with a right-sided parapneumonic effusion and pneumonia who failed initial empirical antibiotics.

Cite
Galliguez T, Tsou PY, Cabrera A, et al. Next-generation sequencing-based clinical metagenomics identifies . Br J Biomed Sci. 2021;78(2):101-105doi: 10.1080/09674845.2020.1827846.
Galliguez, T., Tsou, P. Y., Cabrera, A., & Fergie, J. (2021). Next-generation sequencing-based clinical metagenomics identifies . British journal of biomedical science, 78(2), 101-105. https://doi.org/10.1080/09674845.2020.1827846
Galliguez, T, et al. "Next-generation sequencing-based clinical metagenomics identifies ." British journal of biomedical science vol. 78,2 (2021): 101-105. doi: https://doi.org/10.1080/09674845.2020.1827846
Galliguez T, Tsou PY, Cabrera A, Fergie J. Next-generation sequencing-based clinical metagenomics identifies . Br J Biomed Sci. 2021 Apr;78(2):101-105. doi: 10.1080/09674845.2020.1827846. Epub 2021 Jan 13. PMID: 32993476.
Copy Download .nbib Format: NLM
Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.

Pediatric blood & cancer

Rossoff J, Jacobsohn D, Kwon S, Kletzel M, Duerst RE, Tse WT, Schneiderman J, Chaudhury S.
PMID: 34022093
Pediatr Blood Cancer. 2021 Aug;68(8):e29087. doi: 10.1002/pbc.29087. Epub 2021 May 22.

BACKGROUND: Myeloablative conditioning regimens decrease the risk of relapse in pediatric patients undergoing allogeneic hematopoietic stem cell transplant (HCT) for hematologic malignancies, but cause significant toxicities PROCEDURE: This prospective study evaluated the use of a reduced-toxicity, myeloablative regimen with...

Cite
Rossoff J, Jacobsohn D, Kwon S, et al. Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatr Blood Cancer. 2021;68(8):e29087doi: 10.1002/pbc.29087.
Rossoff, J., Jacobsohn, D., Kwon, S., Kletzel, M., Duerst, R. E., Tse, W. T., Schneiderman, J., & Chaudhury, S. (2021). Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatric blood & cancer, 68(8), e29087. https://doi.org/10.1002/pbc.29087
Rossoff, Jenna, et al. "Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies." Pediatric blood & cancer vol. 68,8 (2021): e29087. doi: https://doi.org/10.1002/pbc.29087
Rossoff J, Jacobsohn D, Kwon S, Kletzel M, Duerst RE, Tse WT, Schneiderman J, Chaudhury S. Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies. Pediatr Blood Cancer. 2021 Aug;68(8):e29087. doi: 10.1002/pbc.29087. Epub 2021 May 22. PMID: 34022093.
Copy Download .nbib Format: NLM
From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R.

Applied health economics and health policy

Xin Y, Gray E, Robles-Zurita JA, Haghpanahan H, Heggie R, Kohli-Lynch C, Briggs A, McAllister DA, Lawson KD, Lewsey J.
PMID: 34671930
Appl Health Econ Health Policy. 2021 Oct 21; doi: 10.1007/s40258-021-00684-y. Epub 2021 Oct 21.

Given the advantages in transparency, reproducibility, adaptability and computational efficiency in R, there is a growing interest in converting existing spreadsheet-based models into an R script for model re-use and upskilling training among health economic modellers. The objective of...

Cite
Xin Y, Gray E, Robles-Zurita JA, et al. From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R. Appl Health Econ Health Policy. 2021;doi: 10.1007/s40258-021-00684-y.
Xin, Y., Gray, E., Robles-Zurita, J. A., Haghpanahan, H., Heggie, R., Kohli-Lynch, C., Briggs, A., McAllister, D. A., Lawson, K. D., & Lewsey, J. (2021). From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R. Applied health economics and health policy, . https://doi.org/10.1007/s40258-021-00684-y
Xin, Yiqiao, et al. "From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R." Applied health economics and health policy vol. (2021). doi: https://doi.org/10.1007/s40258-021-00684-y
Xin Y, Gray E, Robles-Zurita JA, Haghpanahan H, Heggie R, Kohli-Lynch C, Briggs A, McAllister DA, Lawson KD, Lewsey J. From Spreadsheets to Script: Experiences From Converting a Scottish Cardiovascular Disease Policy Model into R. Appl Health Econ Health Policy. 2021 Oct 21; doi: 10.1007/s40258-021-00684-y. Epub 2021 Oct 21. PMID: 34671930.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 157 entries